EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases

Xiaoping Guo, Xu Zuo, Zhengjie Zhou, Yinuo Gu, Haoyu Zheng, Xinlei Wang, Guoqiang Wang, Caina Xu, Fang Wang iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054333 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xiaoping Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Nanoparticles, Respiration Disorders, Respiratory Tract Diseases, Asthma. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Key Laboratory of Pathogen Biology, Key Laboratory of Precision Infectious Diseases of Jilin Province, Jilin Provincial Development and Reform Commission Common Disease Precision Prevention and Control Engineering Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), are critical areas of medical research, as millions of people are affected worldwide. In fact, more than 9 million deaths worldwide were associated with respiratory diseases in 2016, equivalent to 15% of global deaths, and the prevalence is increasing every year as the population ages. Due to inadequate treatment options, the treatments for many respiratory diseases are limited to relieving symptoms rather than curing the disease. Therefore, new therapeutic strategies for respiratory diseases are urgently needed. Poly (lactic-co-glycolic acid) micro/nanoparticles (PLGA M/NPs) have good biocompatibility, biodegradability and unique physical and chemical properties, making them one of the most popular and effective drug delivery polymers. In this review, we summarized the synthesis and modification methods of PLGA M/NPs and their applications in the treatment of respiratory diseases (asthma, COPD, cystic fibrosis (CF), etc.) and also discussed the research progress and current research status of PLGA M/NPs in respiratory diseases. It was concluded that PLGA M/NPs are the promising drug delivery vehicles for the treatment of respiratory diseases due to their advantages of low toxicity, high bioavailability, high drug loading capacity, plasticity and modifiability. And at the end, we presented an outlook on future research directions, aiming to provide some new ideas for future research directions and hopefully to promote their widespread application in clinical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRespiration DisordersRespiratory Tract DiseasesAsthmaPulmonary Disease, Chronic ObstructiveHumansPolylactic Acid-Polyglycolic Acid CopolymerPolyglycolic AcidLactic AcidDrug Carriers

Stichwörter der Autor:innen

PLGA micro-/nanoparticlesasthmachronic obstructive pulmonary disease (COPD)drug deliverytreatment of respiratory diseases

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerPolyglycolic AcidLactic AcidDrug Carriers

Autor:innen und Institutionen

  • Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Department of Biochemistry, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China.

ORCID-Profile: Fang Wang

Förderung

  • Jilin Provincial Key Laboratory of Pathogen Biology
  • Key Laboratory of Precision Infectious Diseases of Jilin Province
  • Jilin Provincial Development and Reform Commission Common Disease Precision Prevention and Control Engineering Laboratory
  • National Natural Science Foundation of China
  • "Medical Science + X" cross-innovation team of the Norman Bethune Health Science of Jilin Uni-versity
  • Health Commission of Jilin Province
  • Special Funding for Fundamental Scientific Research Business Expenses of Central Universities
  • “Medical Science + X” cross-innovation team of the Norman Bethune Health Science of Jilin University

Zitieren

APA

Guo, X., Zuo, X., Zhou, Z., Gu, Y., Zheng, H., Wang, X., Wang, G., Xu, C., & Wang, F. (2023). PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054333

Vancouver

Guo X, Zuo X, Zhou Z, Gu Y, Zheng H, Wang X, et al. PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054333

BibTeX
@article{Guo2023,
  author = {Guo, Xiaoping and Zuo, Xu and Zhou, Zhengjie and Gu, Yinuo and Zheng, Haoyu and Wang, Xinlei and Wang, Guoqiang and Xu, Caina and Wang, Fang},
  title = {PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054333}
}
Kostenlos starten →